R-Sialylation
dissolved in CH3CN (30 mL) and H2O (60 mL) and cooled to 0
°C. To the vigorously stirred mixture was added 4-nitrophenyl
chloroformate (4.32 g, 21.4 mmol, 2.5 equiv) in CH3CN (30 mL)
slowly through a dropping funnel, after which stirring was continued
for 3 h at 0 °C. The resulting mixture was extracted with ethyl
acetate (3 × 100 mL) and the combined extracts were washed with
brine, and then dried over Na2SO4 and concentrated. The residue
was purified by silica gel column chromatography, eluting with
EtOAc then EtOAc/MeOH from 10/1 to 5/1 to give the title
procedure as for 1. Mp 148-149 °C (EtOAc/Et2O/hexanes). [R]14
D
1
+13.4 (c 1.1, CHCl3). H NMR (500 MHZ, CDCl3) δ 7.56-7.26
(m, 5H), 5.54 (dd, J ) 1.5, 6.0 Hz, 1H), 5.34 (dt, J ) 3.0, 7.0 Hz,
1H), 4.42 (dd, J ) 3.0, 12.5 Hz, 1H), 4.34 (dd, J ) 1.5, 9.5 Hz,
1H), 4.19 (dd, J ) 7.0, 12.0 Hz, 1H), 3.98-3.92 (m, 1H), 3.59
(dd, J ) 9.0, 11.0 Hz, 1H), 3.58 (s, 3H), 3.10 (dd, J ) 3.5, 12.0
Hz, 1H), 2.45 (s, 3H), 2.16 (s, 3H), 2.11 (t, J ) 13.0 Hz, 1H), 2.07
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 171.9, 170.7, 170.2, 170.1,
3
168.1 (C-1, JC-1,H-3ax ) 7.50 Hz), 153.4, 136.6, 130.2, 129.0,
compound (6) as white foam (2.67 g, 6.68 mmol, 78% after two
128.3, 87.7, 75.7, 72.5, 70.5, 62.6, 59.1, 53.1, 36.7, 24.7, 21.1, 21.0,
20.9. Anal. Calcd for C25H29NO12S: C, 52.90; H, 5.15; N, 2.47.
Found: C, 53.13; H, 5.11; N, 2.47.
1
steps). [R]14 -186.0 (c 3.2, MeOH). H NMR (500 MHZ, CD3-
D
OD) δ 7.61-7.59 (m, 2H), 7.39-7.35 (m, 3H), 4.69 (dd, J ) 1.5,
10.0 Hz, 1H), 4.62 (dt, J ) 4.0, 12.5 Hz, 1H), 3.83 (dd, J ) 2.5,
11.0 Hz, 1H), 3.75-3.69 (m, 2H), 3.60 (s, 3H), 3.62-3.57 (m,
2H), 2.88 (dd, J ) 4.0, 13.0 Hz, 1H), 2.42 (dd, J ) 13.5, 15.0 Hz,
1H); 13C NMR (125 MHz, CD3OD) δ 169.1, 161.1, 136.3, 129.6,
129.3, 128.7, 89.6, 77.8, 74.4, 70.7, 69.8, 63.5, 58.0, 52.1, 37.0.
ESIHRMS calcd for C17H21N1O8SNa ([M + Na]+) 422.08804,
found 422.08939.
Coupling Protocol with Ph2SO/Tf2O/TTBP in Dichlo-
romethane. A solution of donor 1 (0.11 mmol, 1 equiv), diphenyl
sulfoxide (0.32 mmol, 3 equiv), TTBP (0.22 mmol, 2 equiv), and
activated 4 Å powdered sieves in anhydrous dichloromethane (2
mL) was stirred for 1 h at room temperature under an argon
atmosphere, and then cooled to -78 °C, followed by addition of
Tf2O (0.12 mmol, 1.1 equiv). After 10 min, a solution of the
acceptor (0.22 mmol, 2 equiv) in dichloromethane (1 mL) was
added. The reaction mixture was stirred for 1-6 h at -78 °C and
then warmed to room temperature, diluted with dichloromethane,
filtered through Celite, washed with saturated aqueous NaHCO3,
dried over Na2SO4, and concentrated under reduced pressure. The
glycosides were isolated by column chromatography on silica gel
eluting with THF/Hex systems to afford the sialosides.
Coupling Protocol with NIS/TfOH in Dichloromethane. A
solution of donor 1 (61.3 mg, 0.11 mmol, 1.0 equiv), acceptor (0.16
mmol, 1.5 equiv), and activated 5 Å powdered molecular sieves
(216 mg, 2.0 g/mmol) in anhydrous dichloromethane (2 mL) was
stirred overnight under an argon atmosphere, and then cooled to
-40 °C followed by addition of NIS (58.3 mg, 0.26 mmol, 2.4
equiv) and TfOH (9.5 µL, 0.11 mmol, 1.0 equiv). The reaction
mixture was stirred at -40 °C for 20 min to 2 h until the
disappearance of the donor on TLC, then quenched with triethy-
lamine (22.6 µL, 0.16 mmol, 1.5 equiv) and warmed to room
temperature. The mixture was diluted with dichloromethane, filtered
through Celite, washed with 20% aqueous Na2S2O3 solution, dried
over Na2SO4, and concentrated under reduced pressure. The residue
was purified by column chromatography on silica gel eluting with
THF/Hex system to afford the sialosides.
Methyl (Phenyl 5-amino-5-N,4-O-carbonyl-3,5-dideoxy-2-thio-
D-glycero-R-D-galacto-non-2-ulopyranoside)onate (8). 8 was
prepared from 723 following the same procedure as for 6. [R]15
D
+23.1 (c 3.1, MeOH). 1H NMR (500 MHZ, CD3OD) δ 7.58-7.56
(m, 2H), 7.44-7.41 (m, 1H), 7.38-7.35 (m, 2H), 4.06-4.01 (m,
1H), 3.85-3.79 (m, 3H), 3.69-3.60 (m, 2H), 3.59 (s, 3H), 3.56
(dd, J ) 2.0, 9.0 Hz, 1H), 3.12 (dd, J ) 4.0, 12.0 Hz, 1H), 2.23 (t,
J ) 12.5 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ 169.1, 160.9,
136.4, 130.0, 128.6, 87.9, 78.31, 78.28, 71.6, 70.0, 63.2, 57.0, 52.3,
36.7. ESIHRMS calcd for C17H21N1O8SNa ([M + Na]+) 422.08804,
found 422.08929.
Methyl (Phenyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-car-
bonyl-3,5-dideoxy-2-thio-D-glycero-â-D-galacto-non-2-ulopyra-
noside)onate (donor 1). A solution of compound 6 (2.67 g, 6.68
mmol) in pyridine (20 mL) was treated with Ac2O (24 mL) and
stirred at room temperature overnight, then concentrated under
reduced pressure. The residue was dissolved in anhydrous CH2-
Cl2, treated with EtN(i-Pr)2 (11.6 mL, 66.8 mmol, 10 equiv), and
cooled to 0 °C before acetyl chloride (3.87 mL, 53.4 mmol, 8 equiv)
was added dropwise, then the mixture stirred at 0 °C for 1 h. After
warming to room temperature, the resulting solution was poured
into saturated aqueous NaHCO3 solution, the organic layer was
separated, the aqueous layer was extracted twice with CH2Cl2, and
the combined organic phase was washed with brine, dried over Na2-
SO4, and concentrated under reduced pressure. The residue was
purified by column chromatography on silica gel eluting with
EtOAc/Hex (1:1) to give donor 1 as a yellowish solid (3.49 g, 92%),
which can be further purified by recrystalization from EtOAc/Et2O/
Hex to afford white needle crystals. Mp 152-153 °C (EtOAc/Et2O/
hexanes). [R]14D -117 (c 0.8, CHCl3). 1H NMR (500 MHZ, CDCl3)
δ 7.47-7.31 (m, 5H), 5.52 (t, J ) 2.0 Hz, 1H), 4.96 (td, J ) 1.5,
8.5 Hz, 1H), 4.86 (dd, J ) 2.5, 9.0 Hz, 1H), 4.76 (dt, J ) 4.0, 13.0
Hz, 1H), 4.34 (dd, J ) 2.5, 12.0 Hz, 1H), 3.86 (dd, J ) 8.0, 11.5
Hz, 1H), 3.73 (dd, J ) 9.0, 11.5 Hz, 1H), 3.60 (s, 3H), 2.88 (dd,
J ) 3.5, 13.0 Hz, 1H), 2.49 (s, 3H), 2.32 (t, J ) 12.5 Hz, 1H),
2.12 (s, 3H), 2.05 (s, 3H), 1.93 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 172.5, 171.3, 170.4, 169.8, 167.8 (C-1, 3JC-1,H-3ax ) 2.50
Hz), 153.6, 136.8, 130.2, 129.2, 128.2, 88.3, 75.7, 75.1, 73.9, 72.7,
62.9, 59.6, 52.8, 36.0, 24.8, 21.2, 20.85, 20.76. Anal. Calcd for
C25H29NO12S: C, 52.90; H, 5.15; N, 2.47. Found: C, 53.01; H,
5.15; N, 2.45.
Procedure for the Selective Cleavage of Oxazolidinones. To
a solution of sialoside (0.1 mmol, 1.0 equiv) in methanol (2 mL)
was added a few drops of sodium methoxide solution in methanol
(∼70 µL, 0.3 mmol, 3.0 equiv) at room temperature. The mixture
was stirred at room temperature for 30 min followed by treatment
with Amberlyst 15 ion-exchange resin for 5 min. The mixture was
diluted with methanol and filtered through a sintered funnel packed
with Celite and silica gel. The filter pad was rinsed with methanol
(3 × 5 mL) after filtration. The combined filtrates were concentrated
under reduced pressure to afford the deprotected N-acetamido-
sialosides in quantitative yield without further purification.
Acknowledgment. We thank Dr. D. J. Wink for X-ray
crystallography of donor 1, and the NIH (GM 62160) for
financial support of this work.
Supporting Information Available: X-ray crystal structure of
1, full characterization data, and copies of NMR spectra for new
compounds. This material is available free of charge via the Internet
Methyl (Phenyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-car-
bonyl-3,5-dideoxy-2-thio-D-glycero-R-D-galacto-non-2-ulopyra-
noside)onate (donor 9). 9 was prepared from 8 following the same
JO062431R
J. Org. Chem, Vol. 72, No. 7, 2007 2391